A PYMNTS Company

US: Teva grabbing more of Allergan

By  |  August 3, 2016

Teva Pharmaceutical Industries Ltd. has announced that it would purchase Allergan PLC’s generic pharmaceuticals distributor for $500 million, just a day after Teva closed its much larger deal to buy Allergan’s generics business.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Teva is buying Allergan’s Anda Inc., the fourth-largest distributor of generic pharmaceuticals in the U.S.

    Anda distributes drugs from more than 300 manufacturers to pharmacies across the U.S. and in 2016 Anda is expected to generate more than $1 billion in third-party net revenue.

    As part of the deal, Teva will acquire distribution centers in Mississippi, Florida, and Ohio. Anda will operate as a stand-alone business. The deal is subject to regulatory approval and other closing conditions and is expected to close in the second half of the year.

    Full Content: The Wall Street Journal

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.